124 related articles for article (PubMed ID: 31890491)
1. Functional variant of IL33 is associated with survival of osteosarcoma patients.
Lin Q; Han J; Sun Q; Wen L; Wang S
J Bone Oncol; 2020 Feb; 20():100270. PubMed ID: 31890491
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients.
Koster R; Panagiotou OA; Wheeler WA; Karlins E; Gastier-Foster JM; Caminada de Toledo SR; Petrilli AS; Flanagan AM; Tirabosco R; Andrulis IL; Wunder JS; Gokgoz N; Patiño-Garcia A; Lecanda F; Serra M; Hattinger C; Picci P; Scotlandi K; Thomas DM; Ballinger ML; Gorlick R; Barkauskas DA; Spector LG; Tucker M; Belynda DH; Yeager M; Hoover RN; Wacholder S; Chanock SJ; Savage SA; Mirabello L
Int J Cancer; 2018 Apr; 142(8):1594-1601. PubMed ID: 29210060
[TBL] [Abstract][Full Text] [Related]
3. Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.
López-Mejías R; Genre F; Remuzgo-Martínez S; Robustillo-Villarino M; García-Bermúdez M; Llorca J; Corrales A; González-Juanatey C; Ubilla B; Miranda-Filloy JA; Mijares V; Pina T; Blanco R; Alegre-Sancho JJ; Ramírez Huaranga MA; Mínguez Sánchez MD; Tejera Segura B; Ferraz-Amaro I; Vicente E; Carmona FD; Castañeda S; Martín J; González-Gay MA
PLoS One; 2015; 10(11):e0143153. PubMed ID: 26571131
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis.
Liu JY; Zhu BR; Wang YD; Sun X
Int J Clin Oncol; 2020 Jun; 25(6):1195-1205. PubMed ID: 32215805
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in IL33 and IL1RL1 genes confer susceptibility to HBV-related liver cirrhosis in Chinese Han population.
Ma N; Xu M; Dong Y; Yu F; Zhang X; Gao X; Meng Y; Gao P; Zhou J; Yuan M; Mi Y; Qi S; Li L; Liu D; Liu W; Yang L
Infect Genet Evol; 2021 Oct; 94():104983. PubMed ID: 34197916
[TBL] [Abstract][Full Text] [Related]
6. High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma.
Shu H; Yuan B; Huang Y; Wang L; He B; Sun Q; Sun L
J Orthop Surg Res; 2021 Jan; 16(1):85. PubMed ID: 33509236
[TBL] [Abstract][Full Text] [Related]
7. [Analysis on polymorphism at -509 C/T site of TGF-β1 gene in patients with keloids].
Song M; Liu Y
Zhonghua Shao Shang Za Zhi; 2014 Dec; 30(6):482-6. PubMed ID: 25608783
[TBL] [Abstract][Full Text] [Related]
8. Variants of FasL and ABCC5 are predictive of outcome after chemotherapy-based treatment in osteosarcoma.
Xu L; Xia C; Sun Q; Sheng F; Xiong J; Wang S
J Bone Oncol; 2018 Sep; 12():44-48. PubMed ID: 30065912
[TBL] [Abstract][Full Text] [Related]
9. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
[TBL] [Abstract][Full Text] [Related]
10. Association of
Wu M; Zheng X; Huang J; Hu X
Front Cell Dev Biol; 2021; 9():759542. PubMed ID: 34977013
[No Abstract] [Full Text] [Related]
11. Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy.
Liu S; Yi Z; Ling M; Shi J; Qiu Y; Yang S
Tumour Biol; 2014 Oct; 35(10):9897-904. PubMed ID: 24996541
[TBL] [Abstract][Full Text] [Related]
12. A causal role for circulating miR-34b in osteosarcoma.
Tian Q; Jia J; Ling S; Liu Y; Yang S; Shao Z
Eur J Surg Oncol; 2014 Jan; 40(1):67-72. PubMed ID: 24063968
[TBL] [Abstract][Full Text] [Related]
13. A promoter variant of lncRNA GAS5 is functionally associated with the development of osteosarcoma.
Xu L; Xia C; Xue B; Sheng F; Xiong J; Wang S
J Bone Oncol; 2018 Sep; 12():23-26. PubMed ID: 30013899
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T
Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708
[TBL] [Abstract][Full Text] [Related]
15. [Influence of apatinib and VEGFR2-906T>C polymorphism on clinical outcomes of advanced non-small cell lung cancer patients].
Zhao RH; Zhou YN; Li H; Li R; Zhang WJ; Zong H
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):105-110. PubMed ID: 30669747
[No Abstract] [Full Text] [Related]
16. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
17. Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population.
Wang Z; Wen P; Luo X; Fang X; Wang Q; Ma F; Lv J
Tumour Biol; 2014 Apr; 35(4):3605-10. PubMed ID: 24310504
[TBL] [Abstract][Full Text] [Related]
18. Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis.
Prieto-Peña D; Remuzgo-Martínez S; Genre F; Pulito-Cueto V; Atienza-Mateo B; Llorca J; Sevilla-Pérez B; Ortego-Centeno N; Marquez A; Lera-Gómez L; Leonardo MT; Peñalba A; Narváez J; Martín-Penagos L; Rodrigo E; Miranda-Filloy JA; Caminal-Montero L; Collado P; Sánchez Pérez J; de Argila D; Rubio E; León Luque M; Blanco-Madrigal JM; Galíndez-Agirregoikoa E; Gualillo O; Martín J; Castañeda S; Blanco R; González-Gay MA; López-Mejías R
Sci Rep; 2021 Aug; 11(1):16163. PubMed ID: 34373564
[TBL] [Abstract][Full Text] [Related]
19. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population.
Queiroz GA; Costa RS; Alcantara-Neves NM; Nunes de Oliveira Costa G; Barreto ML; Carneiro VL; Figueiredo CA
Int J Immunogenet; 2017 Apr; 44(2):51-61. PubMed ID: 28266165
[TBL] [Abstract][Full Text] [Related]
20. The association of XRCC1 polymorphism with osteosarcoma risk, clinicopathologic features, and prognosis in a Chinese Han population.
Wu YG; Li HF; Ren YJ; Zou DB; Zhang KN; Xiao X
Cancer Manag Res; 2018; 10():4959-4967. PubMed ID: 30464596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
